Relay Therapeutics (RLAY) Return on Capital Employed: 2021-2025
Historic Return on Capital Employed for Relay Therapeutics (RLAY) over the last 5 years, with Sep 2025 value amounting to -0.49%.
- Relay Therapeutics' Return on Capital Employed fell 2.00% to -0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.49%, marking a year-over-year decrease of 2.00%. This contributed to the annual value of -0.46% for FY2024, which is 7.00% down from last year.
- Latest data reveals that Relay Therapeutics reported Return on Capital Employed of -0.49% as of Q3 2025, which was down 4.60% from -0.47% recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Return on Capital Employed registered a high of -0.09% during Q1 2021, and its lowest value of -0.49% during Q3 2025.
- Over the past 3 years, Relay Therapeutics' median Return on Capital Employed value was -0.45% (recorded in 2024), while the average stood at -0.44%.
- Examining YoY changes over the last 5 years, Relay Therapeutics' Return on Capital Employed showed a top increase of 17bps in 2022 and a maximum decrease of 32bps in 2022.
- Quarterly analysis of 5 years shows Relay Therapeutics' Return on Capital Employed stood at -0.45% in 2021, then rose by 17bps to -0.28% in 2022, then declined by 16bps to -0.44% in 2023, then remained steady at -0.44% in 2024, then decreased by 2bps to -0.49% in 2025.
- Its Return on Capital Employed stands at -0.49% for Q3 2025, versus -0.47% for Q2 2025 and -0.46% for Q1 2025.